Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,463
Recruiting: 820
Ph III recruiting: 96
Growth YoY: +6.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 51–100 of 2,017 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05475171	Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)	recruiting	Phase 2	60	M.D. Anderson Cancer CenterOTHER	1	Sep 17, 2026	clinicaltrials
NCT05758688	PROton Therapy for Post Surgical Treatment of GYNecologic Cancer(PROPS GYN)	recruiting	Phase 2	25	Abramson Cancer Center at Penn MedicineOTHER	1	Sep 17, 2026	clinicaltrials